exRNAdisease

Entry Detail

---



General Information

Database ID: exR0756785 RNA Name: CD74 RNA Type: mRNA Chromosome: chr5 Starnd: - Coordinate: Start Site(bp): 150400041 End Site(bp): 150412929 External Links: ENSG00000019582

Disease Information

Disease Name: Glioblastoma Multiforme Disease Category: Cancers MeSH ID: D005909 Type: Neoplasms/Neoplasms, Glandular and Epithelial Alias: Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell

Expression Detail

GEO ID: GSE106804 Description: Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles Experimental Design: Cancer vs Control Case Disease Type: Glioblastoma Multiforme Case Disease SubType: NA Case Sample: Glioblastoma Multiforme Control Sample: Healthy Number of Case: 13 Number of Control: 6 Number of Samples: 19

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand AKT1 chr14 104769349 104795751 - A4GALT chr22 42692121 42721298 - ACTN4 chr19 38647649 38731589 + AHCY chr20 34280268 34311802 - ACTG1 chr17 81509971 81523847 - AATF chr17 36948954 37056871 + AC006064.6 chr12 6556886 6607367 - AC005258.1 chr19 2269525 2341172 + AHCYL1 chr1 109984765 110023742 + AC023055.1 chr12 55757275 55827546 - AKAP8 chr19 15353385 15379798 - ALDOA chr16 30064164 30070457 + ACTR3 chr2 113890063 113962596 + ACTR2 chr2 65227753 65271253 + AL049629.2 chr11 33698261 33722467 - ACOT9 chrX 23701055 23766475 - AK3 chr9 4709556 4742043 - ACAP1 chr17 7336529 7351477 + AC008982.1 chr19 38817471 38840178 - ADGRE1 chr19 6887566 6940459 + AL669918.1 chr6 32813767 32838822 - AC007192.1 chr19 18153158 18178117 + ACTB chr7 5527148 5563784 - AL590764.2 chrX 71103987 71111575 - AKR1B1 chr7 134442356 134459284 - ALDH18A1 chr10 95605941 95656711 - AC005670.2 chr17 46923133 47049932 + AIP chr11 67483026 67491103 + AKR7A2 chr1 19303965 19312146 - ACIN1 chr14 23058564 23095614 - miRNA targets: miRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa-miR-24-3p chr9 95086064 95086085 + hsa-miR-7-5p chr19 4770700 4770723 + hsa-miR-423-5p chr17 30117095 30117117 + hsa-miR-4687-3p chr11 3856113 3856133 + circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC004687.1 chr17 58330884 58332508 - AC007952.4 chr17 19112000 19112636 - AC016876.2 chr17 7581964 7584086 - AC020663.1 chr16 4730115 4752565 - AL137802.2 chr1 16514645 16515754 + Display:

Experiment Detail

GEO ID: NA Sample Source: NA Source Fraction: NA Platform: NA Method: NA Num of detected RNA Type: NA Num of detected RNAs of this Type: NA Sample treatment protocol: NA RNA Extract protocol: NA RNA library preparation protocol: NA

Reference

PMID: 29330365 Title: Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles. Author: Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL. Journal: Nat Commun. 2018 Jan 12;9(1):175. Description: Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.